The Latest Breaking News from FDA

Explore the emergence of mental health chatbots, their benefits, concerns, and potential impact on mental health care.

Anti-abortion researchers ‘exaggerate’ and ‘obfuscate’ in their scientific papers – but by the time they’re published, it’s too late

This change follows the recent FDA approval of the weight-loss drug for preventing heart attack and stroke in people with overweight or obesity.

The Supreme Court hears arguments Tuesday in a challenge that could limit access to a widely used drug for medication abortions.

The market offers many alternatives to bad desserts. We don’t need the FDA to step in.

The pharmaceutical industry is rapidly expanding, fueled by continued R&D efforts leading to the discovery of new drugs and therapies, biotechnology innovations, and growing medical needs. Thus, let’s take a look at pharma gems Pacira BioSciences (PCRX), Calliditas Therapeutics (CALT), and Astellas Pharma (ALPMY) poised for breakthroughs. Read more….

In the name of safety, politicians did many things that diminished our lives—without making us safer.

Revamping cancer classification to focus on molecular characteristics over organ of origin can result in more effective and timely treatment, a group of doctors has said.

Lawsuit against Gilead Sciences raises concerns about innovation impact in drug development and potential implications on future product development.